MedTech Innovator CEO, Innovator Ventures GP
Paul Grand is Co-GP at Innovator Ventures, a fund leveraging proprietary deal flow of high-performing medical device, diagnostic, and digital health companies.
Grand is also CEO and Founder of MedTech Innovator, the medtech industry's global competition and accelerator, with a mission to improve the lives of patients by accelerating the development of startups transforming the health care system. MedTech Innovator runs its industry accelerator in partnership with 19 leading industry stakeholders such as Johnson & Johnson, Amgen, Baxter, Olympus, W.L. Gore, and many others. Grand has an extensive global network in transformative medical innovation.
Prior to Innovator Ventures and MedTech Innovator, Grand was Managing Director at RCT Ventures, an early-stage life science investor since 2005. At RCT, Grand focused on medtech investments and sourcing innovation. He founded MedTech Innovator as a program within RCT Ventures in 2013, and he left to run MedTech Innovator as a stand-alone company with RCT's support in 2016.
Prior to RCT, Grand was an entrepreneur, founding and / or serving as CEO in eight companies in life sciences and technology, including most recently Imagine Pharmaceuticals, which developed a platform to deliver therapeutics across the blood brain barrier and MicroSurgeon, which developed a thermal ablation device treating solid tumors.
Grand is actively involved in programs to encourage healthcare innovation. He has lectured and mentored students & scientists at numerous universities, including UCLA, Stanford, USC, and UCSF. Grand served as an investment advisor to the LARTA NIH Commercialization Assistance Program for SBIR awardees. He has served on the Oversight Committees for the Coulter Translational Research Partnership Programs at USC and University of Washington. Grand has reviewed proof of concept and commercialization-focused funding programs for the University of California, USC, University of Utah, and University of Colorado.